학술논문
Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status
Document Type
Article
Author
Source
In: Blood . (Blood, 7 April 2022, 139(14):2145-2155)
Subject
Language
English
ISSN
15280020
00064971
00064971